drugset / Trial / NCT00565396
Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fosinopril | Small molecule | 10 mg | Oral |
| Comparator | Fosinopril | Small molecule | 20 mg | Oral |
| Comparator | Losartan | Other / unclassified | 50 mg | Oral |
| Comparator | Losartan | Other / unclassified | 100 mg | Oral |